European Union merger law

Juice Concentrates Market by Type, Application, Ingredient, Form and Region - Global Forecast to 2027 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 22, 2022
Food, Beverage, Manufacturing, Women, Retail, Men, Children, Convenience Store, Family, Consumer, Discount, Variety, Organic Food, Fitness & Nutrition, Department Stores, Agriculture, Natural Resources, Health, Supermarket, Packaging, CAGR, Drink, European Union merger law, Bakery, Confectionery, Tobacco Workers and Grain Millers' International Union, Union, Health, Bakery, Temperature, Taste, Growth, Region, Vegetable, USD, Fruit, SVZ, Single, Color, Food, Garlic, Awareness, Income, Soft drink, Wine, EU, Form

The global juice concentrates market is estimated to be valued at USD 73.7 billion in 2022.

Key Points: 
  • The global juice concentrates market is estimated to be valued at USD 73.7 billion in 2022.
  • The juice concentrates market, based on vegetable type, has been segmented into carrot, cucumber, tomato, onion and garlic and others.
  • Cucumber juice concentrates form a refreshing beverage and can be a post-workout drink for fitness enthusiasts.
  • The juice concentrates market, based on form, is estimated to be dominated by clear concentrates in 2022.

Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase

Retrieved on: 
Thursday, July 22, 2021
Research, Medical devices, Genetics, Other Health, General Health, Pharmaceutical, Health, Science, Oncology, Other Science, Politics of the European Union, Foreign relations of the European Union, European Union, DNA sequencing, Grail, Illumina, Inc., Competition law, Illumina, European Economic Area, European Union merger law

We look forward to presenting our position during the Phase II process, said Charles Dadswell, General Counsel for Illumina.

Key Points: 
  • We look forward to presenting our position during the Phase II process, said Charles Dadswell, General Counsel for Illumina.
  • Illumina is also challenging the ECs jurisdiction to investigate the transaction under Article 22 of the European Union (EU) Merger Regulation.
  • Illumina has filed an action in the General Court of the EU seeking annulment of the ECs jurisdiction to review the acquisition.
  • Illuminas re-acquisition of GRAIL means that millions of citizens across the European Economic Area (EEA) will be able to access life-saving early cancer screening years sooner.